Dystonia, Primary
9
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Local Field Potentials in Dystonia
Agency in Dystonia
Dystonia Genotype-Phenotype Correlation
An Open-label Study to Define the Safety, Tolerability and Clinical Activity of Deutetrabenazine (AUstedo) in Adult Study Subjects With DYsTonia
Enhancing Sensorimotor Processing in Children With Dystonia
Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Effectiveness and Reliability of Hypnosis in Stereotaxy
Task-dependent Operation of a Mechanism Intracortical Inhibition in Dystonia
Study of Speech Disorders , Voice and Swallowing in Primary Dystonia Oromandibular